CAR-T Cell Therapy as Potential Venue for Multiple Myeloma - Bispecific Antibody may provide immuno-oncology in safer venue - 101931

Spotlight
Video

CAR-T Cell Therapy as Potential Venue for Multiple Myeloma - Bispecific Antibody may provide immuno-oncology in safer venue

ASHReport has 275 videos Subscribe Here

Loading........
Description: Joshua Richter, MD from John Theurer Cancer Center discusses CAR-T Cell therapy as potential venue for multiple myeloma and bispecific antibody may provide immuno-oncology in safer venue at the 2017 American Society of Hematology.

Shared By : ASHReport
Posted on : 01/24/18
Added : 11 months ago
Category : Multiple Myeloma